BRUSSELS – 25 January 2018 – ResMed today announced its membership in MedTech Europe, a trade association whose mission is to make innovative medical technology and connected health solutions available to more people, while helping healthcare systems move toward a sustainable path.
MedTech Europe represents roughly 26,000 businesses in the world’s second largest medtech market, estimated at €110 billion ($120 billion) in 2015. The trade association maximizes patients’ access to and use of health-improving, cost-saving medical innovations through:
- Promoting health economics research to show the benefits of medtech; and
- Helping shape pro-medtech policies by directly engaging European Union regulators, politicians and other decision-makers.
ResMed, the world’s healthcare leader in remote patient monitoring with a range of cloud-connected sleep and respiratory care devices sold in Europe, has 11 employees serving on 15 MedTech Europe committees.
Learn more about MedTech Europe: medtecheurope.org
ResMed (NYSE: RMD, ASX: RMD) changes lives with award-winning medical devices and cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 4 million patients remotely monitored every day. Our 6,000-strong team is committed to creating the world’s best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 120 countries. ResMed.com
# # #